UNSPSC 51131716: Reteplase
Commodity
Code facts
- Part of
-
-
51000000
-
51130000
- 51131700
-
51130000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51131716
| NIGP code |
|---|
| 26920 Blood Formation and Coagulation |
Definition
This classification denotes a plasminogen activator with the molecular formula C1736H2653N499O522S22, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DQA630RIE9, more generally known as reteplase. European Medicines Agency schedules reteplase in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10290MIG. The term RETEPLASE is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 8 no. 3 1994, list 34. Most nations schedule reteplase under HS 35079090 and SITC 51691.
As of Q4 2014, RETEPLASE remains the US FDA Preferred Term for this commodity. Reteplase bears US NLM identifiers UMLS ID C0106660 and NCI Concept Code C90972. SMILES: NONE.
About UNSPSC 51131716
UNSPSC 51131716 Reteplase is a Commodity code that does not align with recent state and local procurement activity. The single recent opportunity posted under this code—Sourcewell's RFP #061626 for Law Enforcement Equipment, due June 16, 2026—solicits tactical and protective gear for law enforcement agencies, not the thrombolytic pharmaceutical product the code nominally describes. The mismatch suggests either a tagging error in the source data or a fundamental misclassification in how the opportunity was indexed.
Sourcewell, a Minnesota local government cooperative, issued this RFP on behalf of participating entities across Washington state (Franklin, Grant, Grays Harbor, Chelan, and Yakima counties) and additional jurisdictions nationwide and in Canada. The resulting contract framework would serve law enforcement agencies, K–12 school districts, higher education institutions, tribal governments, and other public entities through Sourcewell's cooperative purchasing vehicle. No recent activity appears in the source under the actual scope of reteplase procurement—cardiac and stroke-care pharmaceuticals sold to hospitals, emergency departments, or health systems. The code shows little relevant recent activity for pharmaceutical buyers in state and local government.
Quick answers
What is UNSPSC 51131716?
UNSPSC 51131716 is Reteplase, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51131716?
UNSPSC 51131716 maps to 1 NIGP code, 26920 Blood Formation and Coagulation.
On GovTribe
See everything under UNSPSC 51131716
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code